OKYO Pharma Limited is a United Kingdome-based biopharmaceutical company. The Company’s operating segment is research and development of biotechnological and pharmaceutical products. The Company focuses on G-protein coupled receptors (GPCR) based therapeutics for eye diseases and non-opioid analgesics for chronic pain. It is developing drug candidates for the treatment of dry-eye, uveitis, ocular and chronic pain. The Company’s therapeutic approach is to develop drug...